Synthesis, Characterization, and Pharmacokinetic Evaluation of a Potential MRI Contrast Agent Containing Two Paramagnetic Centers with Albumin Binding Affinity
- 1 January 2005
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 11 (10) , 3077-3086
- https://doi.org/10.1002/chem.200401207
Abstract
A dinuclear gadolinium(III) complex of an amphiphilic chelating ligand, containing two diethylenetriamine‐N,N,N′,N′′,N′′‐pentaacetate (DTPA) moieties bridged by a bisindole derivative with three methoxy groups, has been synthesized and evaluated as a potential magnetic resonance imaging (MRI) contrast agent. Nuclear magnetic relaxation dispersion (NMRD) measurements indicate that at 20 MHz and 37 °C the dinuclear gadolinium(III) complex has a much higher relaxivity than [Gd(DTPA)] (6.8 vs 3.9 s−1 mmol−1). The higher relaxivity of the dinuclear gadolinium(III) complex can be related to its reduced motion and larger rotational correlation time relative to [Gd(DTPA)]. In the presence of human serum albumin (HSA) the relaxivity value of the noncovalently bound dinuclear complex increases to 15.2 s−1 per mmol of Gd3+, due to its relatively strong interaction with this protein. The fitted value of the binding constant to HSA (Ka) was found to be 104 M−1. Because of its interaction with HSA, the dinuclear complex exhibits a longer elimination half‐life from the plasma, and a better confinement to the vascular space compared to the commercially available [Gd(DTPA)] contrast agent. Transmetalation of the dinuclear gadolinium(III) complex by zinc(II) has been investigated. Biodistribution studies suggest that the complex is excreted by the renal pathway, and possibly by the hepatobiliary route. In vivo studies indicated that half of the normal dose of the gadolinium(III) complex enhanced the contrast in hepatic tissues around 40 % more effectively than [Gd(DTPA)]. The dinuclear gadolinium(III) complex was tested as a potential necrosis avid contrast agent (NACA), but despite the binding to HSA, it did not exhibit necrosis avidity, implying that binding to albumin is not a key parameter for necrosis‐targeting properties.Keywords
This publication has 45 references indexed in Scilit:
- Novel heteroditopic chelate for self-assembled gadolinium(iii) complex with high relaxivityElectronic Supplementary Information (ESI) available: synthesis and analytical data for tpy-DTTA4? and for the complexes. See http://www.rsc.org/suppdata/cc/b4/b400169a/Chemical Communications, 2004
- Potential MRI Contrast Agents Based on Micellar Incorporation of Amphiphilic Bis(alkylamide) Derivatives of [(Gd−DTPA)(H2O)]2−European Journal of Inorganic Chemistry, 2003
- The fate of the radion in models with metastable gravitonJournal of High Energy Physics, 2000
- Direct assessment of water exchange on a Gd(III) chelate bound to a proteinJBIC Journal of Biological Inorganic Chemistry, 1998
- Gd(III) complexes as contrast agents for magnetic resonance imaging: a proton relaxation enhancement study of the interaction with human serum albuminJBIC Journal of Biological Inorganic Chemistry, 1996
- Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1Journal of the American Chemical Society, 1996
- Gadolinium(III) Di- and Tetrachelates Designed for in Vivo Noncovalent Complexation with Plasma Proteins: A Novel Molecular Design for Blood Pool MRI Contrast Enhancing AgentsBioconjugate Chemistry, 1995
- Effect of varying the molecular weight of the MR contrast agent Gd‐DTPA‐polylysine on blood pharmacokinetics and enhancement patternsJournal of Magnetic Resonance Imaging, 1994
- Status of liposomes as MR contrast agentsJournal of Magnetic Resonance Imaging, 1993
- Site-specific water proton relaxation enhancement of iron (III) chelates noncovalently bound to human serum albuminMagnetic Resonance in Medicine, 1991